AKT1 and cancer: We recently demonstrated that truncated RXRα, tRXRα, resulted from limited proteolytic cleavage of RXRα in several human tumors as well as in a number of cancer cell lines, confers tumor growth advantage due to its activation of PI3K/AKT survival signaling [15].